Hence, we propose that peptides/peptidomimetics could compensate the FMRP deficiency restoring the imbalance of protein synthesis and actin dynamics, suggesting a new and promising strategy for treating FXS
Adolescents with obesity prescribed a GLP-1 receptor agonist are less likely to have suicidal ideation or a suicide attempt than those with obesity treated with lifestyle intervention, according to new data
GLOW peptide is a research blend of three compounds BPC-157, TB-500, and GHK-Cu usually sold pre-blended at a 5:1:1 GHK-Cu-dominant ratio
Although evidence from clinical trials has shown GLP-1 RAs to be safe and efficacious in people living with T2DM and renal impairment, their use is uncommon in this patient population
No, they dont
in its 12th acquisition of '26, Lilly enters the psychedelics aisle w/$2.8B upfront move for AtaiBeckley GLP-1 giant, once known for its depression med Prozac, gets 3 clinical-stage brain health drug candidates follows J&J, AbbVie, Otsuka in psychedelics endpoints.news/lilly-bets-2-8 Lilly inked 25% of biopharma industry's acquisitions in 1H26 W/tirzepatides patent cliff far away, Lilly can go shopping in aisles of the supermarket that are a little less populated, said Jacob Van Naarden, head of Lilly BD, in interview w/ @endpts endpoints.news/eli-lilly-domi
